BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11406276)

  • 1. Mouse hepatocyte growth factor activator inhibitor type 1 (HAI-1) and type 2 (HAI-2)/placental bikunin genes and their promoters.
    Itoh H; Kataoka H; Meng JY; Hamasuna R; Kitamura N; Koono M
    Biochim Biophys Acta; 2001 May; 1519(1-2):92-5. PubMed ID: 11406276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic structure and chromosomal localization of the human hepatocyte growth factor activator inhibitor type 1 and 2 genes.
    Itoh H; Yamauchi M; Kataoka H; Hamasuna R; Kitamura N; Koono M
    Eur J Biochem; 2000 Jun; 267(11):3351-9. PubMed ID: 10824123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte growth factor activator inhibitor type 2 lacking the first Kunitz-type serine proteinase inhibitor domain is a predominant product in mouse but not in human.
    Itoh H; Kataoka H; Hamasuna R; Kitamura N; Koono M
    Biochem Biophys Res Commun; 1999 Feb; 255(3):740-8. PubMed ID: 10049781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor.
    Kawaguchi T; Qin L; Shimomura T; Kondo J; Matsumoto K; Denda K; Kitamura N
    J Biol Chem; 1997 Oct; 272(44):27558-64. PubMed ID: 9346890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1.
    Kirchhofer D; Peek M; Li W; Stamos J; Eigenbrot C; Kadkhodayan S; Elliott JM; Corpuz RT; Lazarus RA; Moran P
    J Biol Chem; 2003 Sep; 278(38):36341-9. PubMed ID: 12815039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse hepatocyte growth factor (HGF) activator inhibitor type 2 lacking the first Kunitz domain potently inhibits the HGF activator.
    Kataoka H; Itoh H; Nuki Y; Hamasuna R; Naganuma S; Kitamura N; Shimomura T
    Biochem Biophys Res Commun; 2002 Jan; 290(3):1096-100. PubMed ID: 11798188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin (HAI-2/PB) in human glioblastomas: implication for anti-invasive role of HAI-2/PB in glioblastoma cells.
    Hamasuna R; Kataoka H; Meng JY; Itoh H; Moriyama T; Wakisaka S; Koono M
    Int J Cancer; 2001 Aug; 93(3):339-45. PubMed ID: 11433397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells.
    Parr C; Jiang WG
    Int J Cancer; 2006 Sep; 119(5):1176-83. PubMed ID: 16557597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1.
    Denda K; Shimomura T; Kawaguchi T; Miyazawa K; Kitamura N
    J Biol Chem; 2002 Apr; 277(16):14053-9. PubMed ID: 11805118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of transcripts generated from mouse hepatocyte growth factor activator inhibitor type 2 (HAI-2) and HAI-2-related small peptide (H2RSP) genes: chimeric mRNA transcribed from both HAI-2 and H2RSP genes is detected in human but not in mouse.
    Naganuma S; Itoh H; Uchiyama S; Tanaka H; Nagaike K; Miyata S; Uchinokura S; Nuki Y; Akiyama Y; Chijiiwa K; Kataoka H
    Biochem Biophys Res Commun; 2003 Mar; 302(2):345-53. PubMed ID: 12604353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 2.
    Qin L; Denda K; Shimomura T; Kawaguchi T; Kitamura N
    FEBS Lett; 1998 Sep; 436(1):111-4. PubMed ID: 9771903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of HGF activator inhibitor type 1 but not type 2 along with regeneration of intestinal mucosa.
    Itoh H; Kataoka H; Tomita M; Hamasuna R; Nawa Y; Kitamura N; Koono M
    Am J Physiol Gastrointest Liver Physiol; 2000 Apr; 278(4):G635-43. PubMed ID: 10762618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of hepatocyte growth factor activator inhibitor type 2 (HAI-2)-related small peptide (H2RSP): its nuclear localization and generation of chimeric mRNA transcribed from both HAI-2 and H2RSP genes.
    Itoh H; Kataoka H; Yamauchi M; Naganuma S; Akiyama Y; Nuki Y; Shimomura T; Miyazawa K; Kitamura N; Koono M
    Biochem Biophys Res Commun; 2001 Oct; 288(2):390-9. PubMed ID: 11606055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2.
    Kirchhofer D; Peek M; Lipari MT; Billeci K; Fan B; Moran P
    FEBS Lett; 2005 Mar; 579(9):1945-50. PubMed ID: 15792801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma.
    Morris MR; Gentle D; Abdulrahman M; Maina EN; Gupta K; Banks RE; Wiesener MS; Kishida T; Yao M; Teh B; Latif F; Maher ER
    Cancer Res; 2005 Jun; 65(11):4598-606. PubMed ID: 15930277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironment.
    Kataoka H; Shimomura T; Kawaguchi T; Hamasuna R; Itoh H; Kitamura N; Miyazawa K; Koono M
    J Biol Chem; 2000 Dec; 275(51):40453-62. PubMed ID: 11013244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sites of proteolytic cleavage to release soluble forms of hepatocyte growth factor activator inhibitor type 1 from a transmembrane form.
    Shimomura T; Denda K; Kawaguchi T; Matsumoto K; Miyazawa K; Kitamura N
    J Biochem; 1999 Nov; 126(5):821-8. PubMed ID: 10544273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development.
    Szabo R; Molinolo A; List K; Bugge TH
    Oncogene; 2007 Mar; 26(11):1546-56. PubMed ID: 16983341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor.
    Hashimoto T; Kato M; Shimomura T; Kitamura N
    FEBS J; 2010 Dec; 277(23):4888-900. PubMed ID: 20977675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of hepatocyte growth factor activator inhibitor type 2 (HAI-2) in human testis: identification of a distinct transcription start site for the HAI-2 gene in testis.
    Yamauchi M; Itoh H; Naganuma S; Koono M; Hasui Y; Osada Y; Kataoka H
    Biol Chem; 2002 Dec; 383(12):1953-7. PubMed ID: 12553733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.